spacer
home > ict > autumn 2018 > capturing cancer evidence
PUBLICATIONS
International Clinical Trials

Capturing Cancer Evidence

The Clinical Case

In June 2017, Basch E et al published randomised controlled trials evidence of the benefits of using a digital platform to remotely measure patient-reported outcome measures (PROMs) – clinical assessments that capture the impact of a condition on a patient’s life at a time point – alongside the usual processes of care for patients undergoing chemotherapy for advanced cancer. The study group were found to survive an average of five months longer (which translated to an absolute five-year survival benefit of 8%) than the control group. Additionally, 31% reported quality of life benefits at six months, and emergency room visits were 7% lower (1).

These surprising results were better than those reported by the majority of recently licensed chemotherapy drugs, were more impactful on quality of life, and contributed positively to overall care efficiency and cost effectives.

The reasons for the benefits are because of how the technology allowed the service to better meet the needs of patients. Using remotely collected symptom and outcome data, specialist nurses could monitor patients between appointments and look for treatable problems that may otherwise have escalated and mean patients could no longer tolerate a hospital visit for further doses of chemotherapy, or worse, deteriorate to the point that they are admitted to hospital and deteriorate further.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Tim Williams is the Co-founder and CEO of My Clinical Outcomes – a technology platform that automates the collection and analysis of PROMs in clinical practice. Tim previously worked as an NHS doctor and strategy consultant and has a keen interest in how technology can help improve healthcare services, having also undertaken Professor Michael Porter’s Value-Based Healthcare seminar series at Harvard Business School, US.
spacer
Dr Tim Williams
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PredictImmune announce issuance of new patent in the US in support of commercialisation

PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, today confirmed its latest patent grant in the US. The US patent is part of PredictImmune’s third family of intellectual property (IP) relating to methods for predicting autoimmune disease risk. This follows successful grants across the company’s first family of IP in the UK and Europe in October 2018 and Canada in January this year.
More info >>

White Papers

Tightening Your Supply Chain Against Counterfeits

World Courier

As today’s global pharmaceutical supply chain grows increasingly longer and more complex, each link provides added opportunity for counterfeiters. While pending regulatory changes promise to tighten the supply chain with respect to production and distribution entities and new packaging technologies will make the identification of counterfeit products easier, the logistics of global distribution remains a weak link. How can the pharmaceutical shipper ensure the security of the supply chain over thousands of miles and extended periods of time when the product is no longer in his possession?
More info >>

 
Industry Events

SMi Presents the 11th Adaptive Designs in Clinical Trials Conference 2019

1-2 April 2019, Holiday Inn Kensington Forum, London

SMi Group are proud to announce the 11th annual Adaptive Designs in Clinical Trials conference and exhibition will return to London from the 1st – 2nd April 2019. With the growing popularity in use and acceptance of adaptive designs in clinical trials - demonstrated most recently with the new FDA draft guidance on adaptive designs – there is a pressing need for a forum which explores this increasingly normalized medical methodology.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement